Published 6 hours ago • loading... • Updated 4 hours ago

Novartis lifts profit outlook as new medicines counter generic erosion (NVS:NYSE)

Summary by Seeking Alpha

Novartis raised its 2025 profit outlook after strong demand for newer drugs beat generic pressure.

3 Articles

Seeking Alpha

Lean Right

Novartis lifts profit outlook as new medicines counter generic erosion (NVS:NYSE)

Novartis raised its 2025 profit outlook after strong demand for newer drugs beat generic pressure.

6 hours ago·Ra'anana, Israel

Read Full Article

BizToc

Novartis Hikes Income Forecast, But There Were Caveats Within Its Report

Novartis stock rose slightly early Tuesday on strong third-quarter income, but the company's biggest moneymaker, Kisqali, fell short. The post Novartis Hikes…

4 hours ago

Read Full Article

iatronet.gr

Novartis Raises the Bar for Profits

It needs new drugs to maintain its growth trajectory, as cheaper generics are curbing sales of some of its former top products.

6 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right1Center0Last Updated4 hours agoBias Distribution

100% Right

Bias Distribution

100% of the sources lean Right

100% Right

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

iatronet.gr broke the news 6 hours ago on Tuesday, October 27, 2026.

Sources are mostly out of (0)

Novartis lifts profit outlook as new medicines counter generic erosion (NVS:NYSE)

3 Articles

3 Articles

Novartis lifts profit outlook as new medicines counter generic erosion (NVS:NYSE)

Novartis Hikes Income Forecast, But There Were Caveats Within Its Report

Novartis Raises the Bar for Profits

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Novartis Q3 Profit Declines; Lifts FY26 Core Income View, Backs Sales Outlook

Novartis Reports $2.2bn Hit From Drug Trial Setbacks, but Lifts Guidance

Alexandru Rogobete Announces that He Has Found "the First Concrete Solutions to Prevent Syncope in the Supply of Medicines".

José Abellán, a Cardiologist, Warns About These Medicines: "They Can Cause High Blood Pressure and No One Knows It"

Family Files Lawsuit After 50+ Middle Schoolers Served Pretzels Coated with Oven Cleaner at Lunch

Supreme Court Questions Centre Over Medicine Price Gap, Reserves Order

Similar News Topics

Similar News Topics

More stories like this

Novartis Q3 Profit Declines; Lifts FY26 Core Income View, Backs Sales Outlook

Novartis Reports $2.2bn Hit From Drug Trial Setbacks, but Lifts Guidance

Alexandru Rogobete Announces that He Has Found "the First Concrete Solutions to Prevent Syncope in the Supply of Medicines".

José Abellán, a Cardiologist, Warns About These Medicines: "They Can Cause High Blood Pressure and No One Knows It"

Family Files Lawsuit After 50+ Middle Schoolers Served Pretzels Coated with Oven Cleaner at Lunch

Supreme Court Questions Centre Over Medicine Price Gap, Reserves Order

Novartis lifts profit outlook as new medicines counter generic erosion (NVS:NYSE)

3 Articles

3 Articles

Novartis lifts profit outlook as new medicines counter generic erosion (NVS:NYSE)

Novartis Hikes Income Forecast, But There Were Caveats Within Its Report

Translate IconNovartis Raises the Bar for Profits

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Novartis Q3 Profit Declines; Lifts FY26 Core Income View, Backs Sales Outlook

Novartis Reports $2.2bn Hit From Drug Trial Setbacks, but Lifts Guidance

Alexandru Rogobete Announces that He Has Found "the First Concrete Solutions to Prevent Syncope in the Supply of Medicines".

José Abellán, a Cardiologist, Warns About These Medicines: "They Can Cause High Blood Pressure and No One Knows It"

Family Files Lawsuit After 50+ Middle Schoolers Served Pretzels Coated with Oven Cleaner at Lunch

Supreme Court Questions Centre Over Medicine Price Gap, Reserves Order

Similar News Topics

Similar News Topics

More stories like this

Novartis Q3 Profit Declines; Lifts FY26 Core Income View, Backs Sales Outlook

Novartis Reports $2.2bn Hit From Drug Trial Setbacks, but Lifts Guidance

Alexandru Rogobete Announces that He Has Found "the First Concrete Solutions to Prevent Syncope in the Supply of Medicines".

José Abellán, a Cardiologist, Warns About These Medicines: "They Can Cause High Blood Pressure and No One Knows It"

Family Files Lawsuit After 50+ Middle Schoolers Served Pretzels Coated with Oven Cleaner at Lunch

Supreme Court Questions Centre Over Medicine Price Gap, Reserves Order

Novartis Raises the Bar for Profits

Bias Distribution

Factuality